Anderson MS

General

Full name : Anderson Matt S

First name : Matt S

Mail : Merck & Co., Inc. Rahway NJ 07065

Zip Code :

City :

Country : USA

Email : matt_anderson@merck.com

Phone :

Fax :

Website :

Directory :

References (2)

Title : Safety, tolerability and pharmacokinetics of doravirine, a novel HIV non-nucleoside reverse transcriptase inhibitor, after single and multiple doses in healthy subjects - Anderson_2015_Antivir.Ther_20_397
Author(s) : Anderson MS , Gilmartin J , Cilissen C , De Lepeleire I , Van Bortel L , Dockendorf MF , Tetteh E , Ancona JK , Liu R , Guo Y , Wagner JA , Butterton JR
Ref : Antivir Ther , 20 :397 , 2015
Abstract :
PubMedSearch : Anderson_2015_Antivir.Ther_20_397
PubMedID: 25470746

Title : Odanacatib, a selective cathepsin K inhibitor, demonstrates comparable pharmacodynamics and pharmacokinetics in older men and postmenopausal women - Anderson_2014_J.Clin.Endocrinol.Metab_99_552
Author(s) : Anderson MS , Gendrano IN , Liu C , Jeffers S , Mahon C , Mehta A , Mostoller K , Zajic S , Morris D , Lee J , Stoch SA
Ref : J Clinical Endocrinology Metab , 99 :552 , 2014
Abstract :
PubMedSearch : Anderson_2014_J.Clin.Endocrinol.Metab_99_552
PubMedID: 24276460